MPR drug information now available for iPhone and iPod touch

NewsGuard 100/100 Score

MPR – the most widely used drug reference by clinicians – is now available as a free App for the iPhone and iPod touch. The MPR drug database is also available for free for BlackBerry, Palm, and Microsoft Mobile devices, as well as desktop and laptop computers running Microsoft XP and Microsoft Vista (www.empr.com/download).

The MPR delivers:

  • Over 4,000 up-to-date drug monographs organized by therapeutic category, brand name, generic name, disease, or manufacturer
  • Monographs for prescription and OTC drugs
  • Continuously updated Drug News, Safety Alerts and Recalls, Drugs in the Pipeline
  • Over 30 clinical calculators

For 25 years, medical professionals in the US have relied on the print editions of MPR to deliver up-to-date, concise drug information at the point-of-care. Now the exact same drug information is available on the iPhone and iPod touch. The pharmacist-editors at MPR are dedicated to bringing the highest quality drug information to all clinicians, with the most powerful and flexible clinical decision support tools available.

"The MPR drug information was previously available for all Microsoft platforms, Blackberry and Palm," said Jim Pantaleo, Vice President and Publisher of the MPR product line. "However, many clinicians now own iPhones, so we needed to make the MPR drug information available to them as well. Our goal is to make the MPR available to all clinicians, independent of the phone or mobile device they choose."

This technology is available through the partnership of MPR with US Biomedical Information Systems, Inc. (USBMIS), a software solutions company that specializes in developing interactive, mobile applications for the healthcare industry. "USBMIS is very excited about implementing the reputable content of MPR with our versatile mobile software publishing technology. We hope that this partnership will bring a new dimension to medical point-of-care tools," said Dr. Darwin Ang, CEO of USBMIS.

SOURCE Prescribing Reference LLC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine